Medicinal Cannabis Shows Little Efficacy for Common Mental Health Disorders, Landmark Study Finds
A groundbreaking meta-analysis published in The Lancet, the most comprehensive examination to date of medicinal cannabis across a spectrum of…
GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Landmark Study
A groundbreaking large-scale analysis conducted by an international consortium of researchers has revealed a significant association between the use of…
GLP-1 Receptor Agonists Show Significant Mental Health Benefits, Large Study Reveals
Medications widely prescribed for type 2 diabetes and obesity, including prominent brands such as Ozempic and Wegovy, are demonstrating unexpected…
The Delayed Rise of Depression and Stress in Swedish Fathers Challenges Perceptions of Early Parenthood Mental Health
A groundbreaking study from Sweden has unveiled a surprising and often overlooked pattern in the mental health of new fathers,…
WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health
The Director-General of the World Health Organization (WHO), Dr Tedros Adhanom Ghebreyesus, has completed the first day of a high-profile…
GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study
A groundbreaking, large-scale analysis of nearly 100,000 individuals has revealed a significant association between the use of glucagon-like peptide-1 (GLP-1)…
A Landmark Study in The Lancet Reveals Medicinal Cannabis Ineffective for Common Mental Health Disorders
A groundbreaking systematic review and meta-analysis, published in the prestigious medical journal The Lancet, has delivered a significant blow to…
GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Landmark Study
New research indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely prescribed for type 2 diabetes and…
